期刊文献+

放射治疗在广泛期小细胞肺癌治疗中的价值

The Treatment Value of Radiation Therapy for Extensive Stage Small Cell Lung Cancer
下载PDF
导出
摘要 近20年单纯化疗对ED-SCLC的生存率尚未取得提高.近几年来的临床研究结果表明,胸部放疗在ED-SCLC的治疗方面是有益处的.自2007年起对于化疗缓解后的ED-SCLC患者行PCI已成为常规治疗模式,对于ED-SCLC多器官转移的患者放疗也有着不可替代的作用.
出处 《实用肿瘤学杂志》 CAS 2012年第1期75-78,共4页 Practical Oncology Journal
  • 相关文献

参考文献24

  • 1Slotman BJ,Senan S.Radiotherapy in small-cell lung cancer:lessons learned and future directions[J].Int J Radiation Oncology Biol Phys,2011,79(40):998-1003.
  • 2Govindan R,Page N,Morgensztern D,et al.Changing epidemiology of small-cell lung cancer in the United States over the last 30 years:analysis of the surveillance,epidemiologic,and end results database[J].Clin Oncol,2006,24(28):4539-4544.
  • 3Soeinski MA,Smit EF,Lorigan P,et al.Phase Ⅲ study of pemetrexed plus carboplatin compared with etoposide plus carboplatin in chemotherapy-naive patients with extensive-stage small-cell lung cancer[J].Clin Oncol,2009,27(28):4787-4792.
  • 4Ferraldeschi R,Lorigan P.Extensive-stage small-cell lung Cancer:moving beyond response rate[J]?Ann Oncol,2009,20(5):801-802.
  • 5Chute JP,Chen T,Feigal E,et al.Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer:perceptible progress[J].Clin Oncol,1999,17(6):1794-1801.
  • 6郭其森,于金明.难治复发型小细胞肺癌的治疗进展[J].肿瘤防治杂志,2002,9(5):547-550. 被引量:4
  • 7朱慧,周宗玫,冯勤付,欧广飞,梁军,张湘茹,张红星,陈东福,肖泽芬,王绿化.胸部放疗在广泛期小细胞肺癌治疗中的价值[J].中华肿瘤杂志,2011,33(2):142-146. 被引量:11
  • 8Schiller JH,Adak S,Cella D,et al.Topotecan versus observation after cisplatin plus etoposide in extensive-stage small-cell lung cancer:E7593-a phase III trial of the Eastern Cooperative Oncology Group[J].Clin Oncol,2001,19(8):2114-2122.
  • 9宋丽华,宋现让,张锡芹,齐洁琳,李秀菊,田禾,步兵.小细胞肺癌患者预后因素分析[J].中华肿瘤杂志,2004,26(7):413-416. 被引量:23
  • 10Jeremic B,Shibamoto Y,Nikolic N,et al.Role of radiation therapy in the combined-modality treatment of patients with extensive disease small-cell lung cancer:a randomized study[J].Clin Oncol,1999,17(7):2092-2099.

二级参考文献62

  • 1宋丽华,宋现让,张锡芹,齐洁琳,李秀菊,田禾,步兵.小细胞肺癌患者预后因素分析[J].中华肿瘤杂志,2004,26(7):413-416. 被引量:23
  • 2秦德兴,马金兰,肖建平,汤致强.照射对血—脑屏障促进化疗药物透过性的影响[J].癌症,1996,15(3):189-191. 被引量:13
  • 3陈东福,吕纪马,周宗枚,王绿化,张宏兴,冯勤富,梁军,肖泽芬,张世平,张香茹,殷蔚伯.放射治疗在广泛期小细胞肺癌治疗中的影响[J].医学研究杂志,2006,35(4):15-17. 被引量:16
  • 4[1]Schuette W.Chemotherapy as treatment of primary and recurrent small call lung cancer [ J ]. Lung Cancer, 2001,33 ( Suppl 1 ): 99 - 107.
  • 5[2]Spiro SG, Souhami RL, Geddes, et al. Durating of chemotherapy insmall cell lung cancer:A cancer reseach campaign trial[J]. Br J Can cer, 1989,59(4) :578 - 583.
  • 6[3]Andersen M, Kristjansen HH. Seconded line chemotherapy in smallcell lung cancer [J ]. Cancer Treat Rev, 1990,17(4): 427 - 436.
  • 7[4]Grant SC, Gralla R J, Kris MG, et al. Single-angent chemotherapy trials Ⅰ small cell lung caner 1970 to 1990[J] .J Clin Oncol, 1992, 10(3):484-498.
  • 8[5]Batist G, Ihde DC, zebell A, et al. Small-cell carcinoma o f lung: Reinduction therapy after late ralapse[J ]. Ann Uintern Med, 1983,98 (2) :472 - 474.
  • 9[6]Postmus PE, Berendsen HH, Van zandwijk N, et al. Retreatment withthe induction regimen in small cell lung cancer relapeing after initial response to short term chemotherapy [J ]. Eur J Cancer clin Oncol, 1987,23(9): 1409 - 1411.
  • 10[7]Vincent M, Evans B, smith Ⅰ. First line chemotherapy rechallenge after ralapse in small cell lung cancer[J ]. Cancer Chemother Pharmcol, 1998,21(1):45 -48.

共引文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部